Platelet dysfunction associated with insulin therapy in patients with type 2 diabetes: Please do not throw the baby out with the bathwater!

被引：3

作者：

Scheen, Andre J. ^{[1
]}

Legrand, Delphine ^{[1
]}

机构：

[1] Univ Liege, CHU Liege, Div Diabet Nutr & Metab Disorders, CHU Sart Tilman,Dept Med, B-4000 Cointe Ougree, Belgium

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 05期

关键词：

D O I：

10.1016/j.jacc.2006.11.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：628 / 628

页数：1

共 9 条

[1]

Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4

[2] Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment [J].

Angiolillo, Dominick J. ;

Bernardo, Esther ;

Ramirez, Celia ;

Costa, Marco A. ;

Sabate, Manel ;

Jimenez-Quevedo, Pilar ;

Hernandez, Rosana ;

Moreno, Raul ;

Escaned, Javier ;

Alfonso, Fernando ;

Banuelos, Camino ;

Bass, Theodore A. ;

Macaya, Carlos ;

Fernandez-Ortiz, Antonio .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (02) :298-304

[3] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].

Bhatt, DL ;

Fox, KAA ;

Hacke, W ;

Berger, PB ;

Black, HR ;

Boden, WE ;

Cacoub, P ;

Cohen, EA ;

Creager, MA ;

Easton, JD ;

Flather, MD ;

Haffner, SM ;

Hamm, CW ;

Hankey, GJ ;

Johnston, SC ;

Mak, KH ;

Mas, JL ;

Montalescot, G ;

Pearson, TA ;

Steg, PG ;

Steinhubl, SR ;

Weber, MA ;

Brennan, DM ;

Fabry-Ribaudo, L ;

Booth, J ;

Topol, EJ ;

Frye, RL ;

Amarenco, P ;

Brass, LM ;

Buyse, M ;

Cohen, LS ;

DeMets, DL ;

Fuster, V ;

Hart, RG ;

Marler, JR ;

McCarthy, C ;

Schoemig, A ;

Lincoff, AM ;

Brener, SJ ;

Sila, CA ;

Albuquerque, A ;

Aroutiounov, G ;

Artemiev, D ;

Atkeson, BG ;

Bartel, T ;

Basart, DCG ;

Lima, AB ;

Belli, G ;

Bordalo e Sa, AL ;

Bosch, X .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717

[4] Insulin resistance and hypersecretion in obesity [J].

Ferrannini, E ;

Natali, A ;

Bell, P ;

CavalloPerin, P ;

Lalic, N ;

Mingrone, G .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :1166-1173

[5] The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes [J].

Kahn, SE .

DIABETOLOGIA, 2003, 46 (01) :3-19

[6] Insulin treatment and cardiovascular disease; friend or foe? A point of view [J].

Muis, MJ ;

Bots, ML ;

Grobbee, DE ;

Stolk, RP .

DIABETIC MEDICINE, 2005, 22 (02) :118-126

[7]

Scheen AJ, 2000, DIABETES IN THE NEW MILLENNIUM, P101

[8] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].

Turner, RC ;

Holman, RR ;

Cull, CA ;

Stratton, IM ;

Matthews, DR ;

Frighi, V ;

Manley, SE ;

Neil, A ;

McElroy, K ;

Wright, D ;

Kohner, E ;

Fox, C ;

Hadden, D ;

Mehta, Z ;

Smith, A ;

Nugent, Z ;

Peto, R ;

Adlel, AI ;

Mann, JI ;

Bassett, PA ;

Oakes, SF ;

Dornan, TL ;

Aldington, S ;

Lipinski, H ;

Collum, R ;

Harrison, K ;

MacIntyre, C ;

Skinner, S ;

Mortemore, A ;

Nelson, D ;

Cockley, S ;

Levien, S ;

Bodsworth, L ;

Willox, R ;

Biggs, T ;

Dove, S ;

Beattie, E ;

Gradwell, M ;

Staples, S ;

Lam, R ;

Taylor, F ;

Leung, L ;

Carter, RD ;

Brownlee, SM ;

Fisher, KE ;

Islam, K ;

Jelfs, R ;

Williams, PA ;

Williams, FA ;

Sutton, PJ .

LANCET, 1998, 352 (9131) :837-853

[9]

Watala C, 2005, PHARMACOL REP, V57, P42

← 1 →